Exact Sciences Reports Q1 Loss

Cologuard Maker Exact Sciences Slashes Outlook as Losses Mount

Exact Sciences shares plunged Wednesday after the company reported widening losses. · The maker of the Cologuard colon cancer screening test ...

Exact Sciences' Q1 Loss Narrows, Revenue Jumps - MarketScreener

Exact Sciences reported a Q1 loss of $0.42 per share, narrowing from a loss of $1.04 per share. Analysts polled by Capital IQ expected a loss of $0.76 per ...

Exact Sciences Q1 Revenues Up 115 Percent | GenomeWeb

The firm reported that revenues from screening products rose 35 percent year over year to nearly $220 million.

Exact Sciences (EXAS) Q1 2024 Earnings Call Transcript

First quarter revenue of $638 million grew 6% on a reported and core revenue basis. Screening revenue of $475 million increased 7%. Recall, ...

Exact Sciences Reports Q1 Loss, Joins Beyond Meat, Duolingo And ...

U.S.stock futures were lower this morning, with the Dow futures falling around 100 points on Thursday.Shares of Exact Sciences Corporation ...

Exact Sciences Announces First-Quarter 2024 Results (Business Wire)

Despite the revenue growth, Exact Sciences reported a net loss of $110 million or $0.60 per share, compared to a net loss of $74 million or ...

Exact Sciences reports 3Q loss, acquisition | Business - GMToday.com

MADISON — Exact Sciences Corp. on Tuesday reported a loss of $219.9 million in its third quarter.

said - SEC.gov

Exact reported a net loss of ($3.8) million, or ($0.13) a share, for the first quarter of 2009. The company had a net loss of ($2.5) million, or ($0.09) a share ...

Exact Sciences announces first-quarter 2024 results - Medical Buyer

Exact Sciences Corp. announced that the company generated revenue of $638 million for the first quarter ended March 31, 2024, ...

Exact Sciences reveals $175M public offering amid Q2 losses

Exact Sciences ($EXAS) raked in $175 million in a public offering to dial up development of its stool-based test for colorectal cancer, ...

Exact Sciences doubles first-quarter revenue, but sales still ...

Exact Sciences (Nasdaq: EXAS) reported first quarter revenue of ... loss of $105.7 million, or 71 cents per share. In 2019, the maker ...

Exact Sciences Announces First Quarter 2023 Results - PR Newswire

MADISON, Wis., May 9, 2023 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, ...

Exact Sciences (EXAS) Reports Q1 Loss, Tops Revenue Estimates

Exact Sciences (EXAS) came out with a quarterly loss of $0.50 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.42 per share ...

Exact Sciences: Q1 Earnings Snapshot - WTOP News

MADISON, Wis. (AP) — MADISON, Wis. (AP) — Exact Sciences Corp. (EXAS) on Wednesday reported a loss of $110.2 million in its first quarter.

Exact Sciences shares rise on 24% Q1 revenue growth, higher 2023 ...

Exact Sciences after the close of the market on Tuesday said its first-quarter revenue rose 24% to $602.5 million from $486.6 million in the ...

Exact Sciences Announces First Quarter 2021 Results - Stock Titan

Exact Sciences Corp. reported first-quarter 2021 revenue of $402.1 million, up 16% from $347.8 million in Q1 2020. Screening revenue grew by ...

What You'll Want to Know About Exact Sciences' Q1 Earnings

How did Exact Sciences' bottom line look in the first quarter? The company reported a GAAP net loss of $83 million, or $0.66 per share, versus a ...

Exact Sciences Shares Drop 10% on Earnings Miss - Investing.com

However, the net loss widened from the $74 million, or -$0.42 per share, reported in the first quarter of 2023, leading to the negative investor ...

Exact Sciences 2Q23 Earnings Presentation

Please refer to our first- quarter 2024 earnings release for discussion of non-GAAP financial measures and reconciliations to GAAP financial ...

Exact Sciences Reports Q1 Loss, Joins Beyond Meat, Duolingo And ...

Beyond Meat, Inc. BYND. shares declined 13.4% to $7.11 in pre-market trading after the company reported a wider-than-expected loss for its first ...